Home

Prescribing & Medicines Management
page PM1
July 2004


Features


Pharmacists in St Helens take on new services in advance of contract deal

Pilot projects in St Helens Primary Care Trust anticipate the new pharmacy contract. Debbie Andalo investigates

Community pharmacists in the North West are already putting the new contract to the test, despite the delays in the Government’s, the NHS and the profession’s negotiations in reaching a national agreement. Services which will be given enhanced status under the new contract, such as minor ailments management and providing emergency hormonal contraception, are being offered by pharmacists in St Helens Primary Care Trust in a series of pilot projects which will be rolled out across the district in the next 18 months.

The PCT has invested nearly £200,000 in the initiative — to cover the cost of pharmacy time and increased drugs costs — with 22 of the district’s 38 pharmacies taking part. Senior primary care pharmacist and community pharmacy lead pharmacist Davina Halsall said: “This is all about increasing our capacity to achieve our targets in order for the people of St Helens to get the best out of their medicines — the pharmacists have the skills to help us increase our capacity.”

The PCT has deliberately developed the role of the community pharmacist as part of its overall strategy. Historically the responsibilities of the profession have been allowed to develop in an ad hoc way, Mrs Halsall admitted. She said: “Before now there wasn’t any thought about how it all fitted into the bigger, wider picture. But now, for example, pharmacists offering the emergency hormonal contraception service fits in with our priority to reduce teenage pregnancies, while the support they offer to asthma inhaler users came about because locally we have high levels of chronic obstructive pulmonary disease and respiratory disease.”

Other services that some pharmacists are taking on for the first time are a needle exchange scheme and supervision of methadone consumption for drug misusers, a minor ailments service and smoking cessation counselling. All services have been given enhanced service status under the new contract. Seven of the pharmacies are also involved in a national pilot — one of only three in the country — to offer direct support to patients with Parkinson’s disease.

Pharmacists rely on an agreed pro forma to keep GPs informed about their patients and a team of primary care support pharmacists are on hand to offer any extra advice or help to the pharmacists who have taken on these new responsibilities.

The new roles for pharmacy reflect the PCT’s strategies for medicines management and community pharmacy — the priority was not the new contract, Mrs Halsall said. But she added: “All these services which we have thought for pharmacy do fit into the framework of the new contract — if it ever gets approved and funded.”

The PCT acknowledged right from the start that if pharmacists were to offer these extra services it would cost them time. Mrs Halsall explained: “If you consider that pharmacists can get £1 for dispensing — without talking to a patient — and they can dispense one item a minute, then I think if you expect them to have a five-minute consultation with the patient you have to reimburse them.”

Phil O’Neil is one of the community pharmacists who, since last year, has taken on a range of additional services. He admitted that the extra money they generate is noticeable. Giving minor ailments advice, he estimates, has brought in on average an additional £600 a month while offering smoking cessation counselling has boosted income by around £3,000 a month of which 25 per cent, he believes, is probably profit. He said: “This is money which wasn’t there before. It’s noticeable. There is also the added benefit that by offering these services it is bringing people into the pharmacy who weren’t coming in before. We are getting more and more prescriptions — patients are seeing the services which we provide and feel that we are offering a really professional service so they decide to bring their prescriptions to us as well.”

Mr O’Neil has been offering patients and customers minor ailments advice by working to an agreed formulary of over-the-counter medicines and to a list of conditions agreed with the PCT. The conditions include hay fever, constipation, head lice, headaches and temperatures. He explained: “If, however, somebody comes in with a minor ailment which we cannot support and we feel they need to see a doctor there is the ability for us to fast track the patient to the practice for a GP appointment.”

The pharmacist who manages Knights Pharmacy is also involved in offering patients smoking cessation counselling. Patients can either be referred to him by the GP for a session which takes place in the pharmacy’s consulting room, or patients can self-refer. The initial consultation takes half an hour but with two pharmacists working in the pharmacy he has the flexibility he needs to offer the service. He said: “Sometimes if a patient just comes in off the street and wants advice about smoking cessation I can see them straight away. If not I can arrange a consultation for them at a later date.”

Working to patient group directions the pharmacist also offers female patients trimethoprim for uncomplicated urinary tract infection and he can also give chloramphenicol for conjunctivitis. The pharmacy also supervises methadone consumption for 12 patients.

Expanding pharmacy services in the community has been popular with patients and brings professional satisfaction. Mr O’Neil’s advice to other pharmacists who may be reluctant to adopt these new professional roles was simple. He said: “I think people have to be positive and look at these new services not as new work, but as another income stream and a way to improve patient care. Anybody interested in doing what we are doing should go and speak to their PCT. Fourteen years ago when I qualified I don’t think I ever thought that this was the future for pharmacy but over the past couple of years I have begun to believe that this is the direction in which the profession should be going.”

Back to Top


©The Pharmaceutical Journal